CatalystPit
TerminalPit ConsensusInsidersPoliticiansInstitutionsNewsScreener

IBRXImmunityBio, Inc.

NASDAQ · Biological Products, (No Diagnostic Substances)
Last close $9.44 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryBiological Products, (No Diagnostic Substances)
Market cap$10.00B
RECENT INSIDER TRADES
  • 2026-10-06 · Simon Barry J. (Director) · SELL
  • 2026-10-06 · Cohen Cheryl (Director) · OTHER
  • 2026-10-06 · Cohen Cheryl (Director) · SELL
  • 2026-07-06 · Cohen Cheryl (Director) · OTHER
  • 2026-07-06 · Cohen Cheryl (Director) · SELL
INSTITUTIONAL OWNERSHIP
Institutional holders428
Shares held248,083,311
Value$1.89B
Percent of shares outstanding23.41%
As of quarter end2026-06-30
RECENT NEWS
  • ImmunityBio director Cheryl Cohen sells $851,088 in shares
  • ImmunityBio director Barry Simon sells $268,760 in stock
  • ImmunityBio (IBRX) Meeting With Turkish President Fuels Expansion Hopes, Shares Climb 10%
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
ImmunityBio, Inc. (IBRX) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit